Open an account

Arcadia Biosciences

RKDA · NASDAQ

$0.153+$0.008 (+5.52%)TodayMarket closed ·
Prev close $0.145

RKDA analyst rating

This isn't available right now. Refresh to try again.

The case for and against

Updated Nov 30, 2024

Bull case

Arcadia Biosciences Inc. has demonstrated a positive trajectory in revenue growth, with 2024 revenue estimates rising to $5.4 million, an increase from previous forecasts, and a reported 2Q24 revenue of $1.3 million that exceeded expectations. Streamlined operations have resulted in significant cost savings, achieving $2 million in 2023 and projecting annual savings of $3 million to $4 million moving forward. Additionally, the company's expansion of its consumer brand offerings, particularly with the introduction of new flavors for Zola coconut water, positions Arcadia favorably in the growing better-for-you product segment, which constitutes nearly 20% of the market and continues to outpace traditional products.

Bear case

Arcadia Biosciences Inc. reported a significant revenue shortfall in its fourth quarter of 2023, generating only $0.8 million compared to an estimate of $1.8 million, and a steep decline from the prior year's revenue of $9.1 million. The company also faced a substantial net loss of $10.64 per share, reflecting operational challenges exacerbated by recent asset divestitures, particularly the loss of the GoodWheat franchise, which has diminished revenue visibility. Consequently, the company's full-year 2023 revenue of $5.3 million fell short of expectations, prompting a downward revision of future revenue estimates, further magnifying concerns regarding its financial stability and growth potential.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.